Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus sufentanil for postoperative analgesia in adults
ChiCTR2100047881Phase 4Not yet recruiting
- Sponsor
- Chengdu Public Health Clinical Medical Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Chengdu Public Health Clinical Medical Center. Primary endpoint: Pain score. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100047881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047881.